Mayne Pharma Group Limited
MAYNF
$3.29
-$0.23-6.54%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -85.14M | -99.80M | -114.34M | -80.18M | -46.09M |
| Total Depreciation and Amortization | 41.95M | 43.32M | 44.46M | 33.94M | 23.44M |
| Total Amortization of Deferred Charges | 3.27M | 2.90M | 2.50M | 1.75M | 1.00M |
| Total Other Non-Cash Items | 35.95M | 51.33M | 66.96M | 41.37M | 15.83M |
| Change in Net Operating Assets | 4.18M | -2.64M | -9.50M | -11.23M | -12.95M |
| Cash from Operations | 224.40K | -4.89M | -9.93M | -14.35M | -18.76M |
| Capital Expenditure | -7.69M | -6.48M | -5.22M | -3.64M | -2.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 4.51M | 4.51M | 4.51M | 2.25M | -- |
| Other Investing Activities | -35.62M | -262.60K | 35.55M | 40.77M | 45.98M |
| Cash from Investing | -38.79M | -2.23M | 34.85M | 39.38M | 43.90M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.94M | -9.30M | -14.67M | -13.73M | -12.80M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | -5.47M | -10.93M | -10.93M | -10.93M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.03M | 4.89M | 5.75M | 4.64M | 3.53M |
| Cash from Financing | 59.30K | -6.44M | -12.97M | -13.08M | -13.20M |
| Foreign Exchange rate Adjustments | 1.82M | 644.20K | -549.20K | -821.70K | -1.09M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.69M | -12.91M | 11.41M | 11.13M | 10.85M |